L Landec Corp
L
Chiusa
SettoreConsumatore difensivo
0
Panoramica
Variazione del prezzo dell'azione
24h
Minimo
Massimo
Entrata | -8.9M -15M |
|---|---|
Vendite | -7.9M 23M |
Margine di Profitto | -64.588 |
Dipendenti | 382 |
Raccomandazioni | Fortemente da comprare |
|---|---|
Previsioni per 12 mesi | +14.84% upside |
Utili prossimi | 9 set 2026 |
|---|
Capitalizzazione di Mercato | 39M 178M |
|---|---|
Apertura precedente | 0 |
Chiusura precedente | 0 |
Notizie sul Sentiment di mercato
By Acuity
50%
50%
51 / 131 Classifica in Consumer defensive
Landec Corp Grafico
Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.
Chi Siamo Landec Corp
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacturing of injectable grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.